{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "DECADES of medical wariness about using drugs for weight loss seem to have melted away with the introduction of two new prescription regimens that offer the appetite control of amphetamines but without the frightening side effects and addictive properties of these dangerous drugs. One is a combination of two long-marketed weight-loss aids, fenfluramine and phentermine, commonly called ''fen/phen,'' and the other is a newly approved refinement, dexfenfluramine, sold under the trade name Redux. All three drugs work by changing the levels of brain chemicals that influence appetite and cravings.", "headline": {"main": "Personal Health", "kicker": "Personal Health"}, "abstract": "Jane Brody Personal Health column on new prescription weight-loss regimens that offer appetite control of amphetamines, but without their side effects and addictive dangers; one is combination of two long-marketed weight-loss aids, fenfluramine and phentermine, and second is dexfenfluramine sold as Redux; drugs, which change levels of brain chemicals that influence appetite and cravings, have helped hundreds of obese patients, but are not for casual use; Dr George Blackburn warns they are only adjunct to healthier low-fat diet and exercise; drugs are meant to help only for people with biological basis for weight problems (S)", "print_page": "12", "word_count": 1182, "_id": "4fd1f5df8eb7c8105d74fa8a", "snippet": "DECADES of medical wariness about using drugs for weight loss seem to have melted away with the introduction of two new prescription regimens that offer the appetite control of amphetamines but without the frightening side effects and addictive...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/10/30/us/personal-health-041335.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BLACKBURN, GEORGE"}, {"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "DIETING"}, {"name": "subject", "value": "REDUX (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PHENTERMINE (DRUG)"}, {"name": "subject", "value": "DEXFENFLURAMINE (DRUG)"}, {"name": "subject", "value": "FENFLURAMINE (DRUG)"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "Brody", "rank": 1, "role": "reported", "organization": ""}], "original": "By Jane E. Brody"}, "document_type": "article", "pub_date": "1996-10-30T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 1, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}